Company intelligence / Profile preview

NanoEntek

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

NanoEntek has commercialized multiple innovative devices for life science research and clinical diagnostics. Their lab-on-a-chip-based platforms have achieved global market penetration—most notably with automated cell counters like Countess (~30% global share), live-cell imaging systems such as JuLI Stage, high-throughput fluorescence analyzers like EVE HT FL, the ADAM series of white blood cell counters adopted by the American Red Cross for QC in blood banking/transfusion medicine. They have also received US FDA approval for several POCT devices including hormone assays.

Therapeutic areas: Men's HealthEndocrinologyHematology
Modalities: Device (cell counters, imaging systems)Diagnostic device (lab-on-a-chip)Microfluidic chip technologyElectroporation system (for gene transfection)Imaging analyzer
Industry: Pathology

Partnerships

Exclusive partnership with L'Oréal Groupe to develop personalized skin analysis hardware using lab-on-a-chip technology ("L'Oréal Cell BioPrint")American Red Cross—ADAM-rWBC selected as standard equipment for blood quality control in transfusion medicineOther global distribution partners not individually listed

Beyond the preview

Go deeper on NanoEntek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoEntek.

Explore the full profile